IM Cannabis Corp (TSE:IMCC) has released an update.
IM Cannabis Corp. (IMCC) has appointed Shmulik Arbel to its board of directors and is refocusing its growth strategy on the Israeli and European cannabis markets, particularly in medical distribution and retail. Exiting the Canadian market, IMCC aims to enhance efficiency and capitalize on European market opportunities. The company also relaunched premium cannabis strains in Israel and is adapting to global economic challenges, including inflation and supply chain disruptions, while navigating political instability and anticipating positive impacts from Israeli regulatory reforms.
For further insights into TSE:IMCC stock, check out TipRanks’ Stock Analysis page.
